NCT01099332 Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT01097096 Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients Status COMPLETED Phase PHASE2
NCT01095744 Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease Status COMPLETED Phase N/A
NCT01094340 Thalidomide for Patients With Mild to Moderate Alzheimer's Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT01093664 Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 Status COMPLETED Phase PHASE1
NCT01082965 Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease Status TERMINATED Phase NA
NCT01079819 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 Status COMPLETED Phase PHASE1
NCT01073228 Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01072812 Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment Status TERMINATED Phase PHASE1
NCT01068353 Safety and Tolerability of Etanercept in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01066546 An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT01066481 A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease Status WITHDRAWN Phase PHASE2
NCT01058941 Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01055561 A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia Status COMPLETED Phase PHASE1
NCT01054976 The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT01049555 Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research Status COMPLETED Phase NA
NCT01047579 A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE4